Treatment of Inflammatory Bowel Disease with Biologics

11

50. Zhu Y, Hu C, Lu M, et  al. Population pharmacokinetic modeling of ustekinumab, a human
    monoclonal antibody targeting IL-12/23p40, in patients with moderate to severe plaque pso-
    riasis. J Clin Pharmacol. 2009;49:162–75.


51. Zhou H, Hu C, Zhu Y, et al. Population-based exposure-efficacy modeling of ustekinumab in
    patients with moderate to severe plaque psoriasis. J Clin Pharmacol. 2010;50:257–67.


52. Feagan BG, Sandborn WJ, Gasink C, et al. Ustekinumab as induction and maintenance therapy
    for Crohn’s disease. N Engl J Med. 2016;375:1946–60.

1 Mechanism of Action and Pharmacokinetics of Biologics